Skip to content
PodSubs
ShowsPeopleGuestsJobsNewsEvents
More
BlogPodCred
Menu
ShowsPeopleGuestsJobsNewsEventsBlogPodCredNetworksSign in
Join nowSign in
  • Shows
  • People
  • Jobs
  • News
  • More
    • Guests
    • Events
    • Blog
    • PodCred
    • Networks
    Join nowSign in

Becker’s Payer Issues Podcast

Becker’s Payer Issues Podcast artwork

Rising Healthcare Costs, Prior Authorization Reform and the Future of Health Insurance with Sean Robbins

Nov 11, 202623 minAudio
ShareXLinkedInFacebookWhatsAppEmail

In this episode, Sean Robbins, Chief Operating Officer at Blue Cross Blue Shield Association, discusses the forces driving rising healthcare costs, the growing impact of specialty drugs and efforts to streamline prior authorization. He also explores AI's role in health insurance, payer-provider collaboration and the importance of putting members at the center of healthcare decisions.

Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.

Transcript

From the show. Tap a time to play from there.

- Hello, everyone. This is Jacob Emerson with the - Becker's Payor Issues podcast. - I'm thrilled today to be joined by Sean - Robbins who serves as the chief operating officer - at the Blue Cross Blue Shield Association. - Sean, appreciate you taking the time to be - with me on the podcast and, starting your - morning with me. Thanks for having me, Jacob. - Glad to be here. - Absolutely. - So, Sean, you've you've been in the industry - for a long time, and I'm sure some - of our listeners will recognize your name. Of - course, you served as the the Blue Shield - of Idaho president for a few years. So - walk us through your career background in health

- care and then bring us up to speed - on what you're doing today at the association. - Yeah. Happy to. Well, look, I - I had the fortuitous opportunity to come into - health care, a little different path than many. - I came in, - working on from the public policy perspective under - a four term governor on the West Coast, - and that's actually what ignited my interest in - health care, - about fifteen years ago. - And over the course of the last, - particularly ten years, I've seen the blues - from four different angles as a holding company

- to your point as president of of a - p and l in in Idaho running one - of the blues, - as a a board member of this national - association - and and since '21, - on the management team of the association. So, - over that decade, I've seen the blues from - these four very - unique perspectives and seen the health care system, - from those... From both the local and the - national perspective, which, - you know, it's the work I'm doing here - at the association today as COO is trying - to align 31 different independent companies that are

- blues across - the 110,000,000 - people that we serve. And so overseeing everything - in health plan operations from commercial markets, government - markets, and the federal employee program. - Absolutely. So you've been in this industry for - for a long time. You've, you've clearly seen - a lot. And I wonder what your take - is on on what we're seeing as we - head into next year, - in terms of renewals and what health insurance - costs... Commercial health insurance costs are expected to - do, in 2027 - in terms of,

- premiums. - We're we're seeing employers project health care costs - to rise roughly eight to 11% - next year depending on the source you look - at, - and that's probably the largest increase in around - two decades. So - what what is ultimately driving that right now, - and and how should we be thinking that - contextually with, with what you've seen across your - career? - Yeah. There's... - So next year's next year's premium increases as... - With true that every year's premium increases is - a function of the underlying cost of care.

- A a premium is a receipt. It's a - reflection, - of the cost of care of the physician - practices, the hospital - costs, the drug costs, - and then there's subcategories - of drug costs. And I think oftentimes in - our in our culture, we confuse health insurance - premiums with the cost of health care. And - in fact, it's just a reflection of the - cost of care. So if you if you - get below the surface of the premium increases - and you look at what's driving cost, right, - the significant amount of blue companies that we're

- talking to today, I wanna say four of - every five of those blues today surveyed said - that drug spending was a major driver of - the premium increases - in 2027. - And when I was on the plan side - working in a local market, you know, the - the challenge wasn't that this was just a - premium increase - in concept. It hit small and medium sized - businesses particularly hard because it ate up capital - that otherwise would be used to hire or - invest in capital expenditures. - And so it has... It... It's it's an

- economic impact. It's not just a a cost - impact to the p and l of these - companies. And so drugs - drugs is big. And particularly, if you go - even further and double click in, you look - at this cost, the rising cost of specialty - drugs, - is accelerating - fastest than any other category and continue... Has - been the case for the last few years - and continues to be going into next year. - Yeah. No. Absolutely. And I know we've seen... - To to note on your point, - we've seen a lot of the Blues plans - really, - highlight GLP one spending over the last couple

- of years Yeah. In their earnings reports, that - they've made public. And and I know AI - has also started to pop up recently in - terms of being cited. - I know that's, - re... The the association has done some research - on the effects of that as well. So - we'll get into that. But I wonder, you - know, with with all that being said, new - initiatives, new programs from from the association or - from Blues plans more broadly - that that you would wanna highlight for us - on on how the system is working to - bring down costs for members, for employers,

- how you how you all are trying to - tackle some of these, - some of these newer problems, - driving up the cost of care. - There's the work we've always done as Blues - and as a system and, frankly, all payers - for that matter is, - you know, we make a pact. We make - a promise with all of our members that - that we're coming together to to negotiate better - prices on your behalf. - And - using that collective, - power - to - create access and try to create affordable access - for care for our members when they need

- it. - That has been and always will be a - core value proposition of every payer. - Your your question is what's new on top - of that. Right? What are we doing uniquely - and differently, not just Blues, but all payers - for that matter? And and I think to - your point - on - on GLP ones as an example or the - specialty drug category that I mentioned in in - your last question, - we're doing some unique work right now to - attack specialty, - medicine costs. And, - because it's the fastest growing category of drug

- spend, - it's important that we get that under control. - So that's a category where we're we're uniquely - focused beyond the core value prop as an - insurer. - Number two, and we hear this from a - lot of our employer customers today, not just - employers, but particularly employers, - is trying to balance the cost of access, - with the cost of that care. And so - in some cases, many employers are actually willing - to have - maybe a smaller network, - if it means more affordability. - So there's the lever that can be pulled

- around network access. Now - that's challenging because most people want to have - any doctor anywhere at any time in their - network available to them. - But particularly for large self funded accounts where - they have, the ability to pull those levers, - we're hearing significant amount of interest in - helping members get the care they need by - focusing them on high value providers. - And I think that's where the technology and - the data come in, - in particular, as we we sit on a... - An analytics engine that allows us to understand

- where the best care is being delivered - at the best cost and value, - and then figuring out how to empower our - customers to guide them to that care versus - the care that exists in the network that - might be higher cost and of, frankly, lower - quality. - Interesting. - Interesting. - Let me let me switch gears here, Sean, - and talk a little bit about, - something that continues to get headlines, - both within trade publications like ours, but then - in also national publications alike,

- around prior authorization and the work that plans - have been doing, - for years now, but it really seems to - be ramping up this year with a lot - of new requirements coming online from the federal - government and and, of course, going into the - next year as well. And so the industry - widely made a pledge about 50 insurers or - so, - last year to reduce prior auth requirements. - And then we got some some data from - you all and from AHIP, - saying that 11% - have been reduced or cut, - as a whole or of total requirements.

- Reporting requirements around prior auth for public public - plans - went into effect earlier this year, so we've - got some new data there. And then, of - course, electronic exchange, - requirements going to affect in the new year. - So a lot of different stuff going on - there. - So so where do you... Where... How would - you describe where things stand today with - prior authorization, - how much of a headache it is or - still is not? Maybe what, - the wider public doesn't - fully understand about - how tough of an issue it is to - tackle for for an organization like yours and

- for the wider industry. - Yeah. It's a complex issue and probably requires - a little bit of a a detailed answer. - And and, - so I'll try not to drone on. - Look. Behind every prior authorization is a real - human being. Let's start there. And I received - the same prior authorization requirements as anyone else - does in my family. So - it's a pain point within the system - of health care in general, and we all - share in that pain point. - Before I'm a COO of of a major

- payer institution, I'm a father, and I'm a - husband, and I'm a human being. - And I don't want to have the health - care process be harder than it needs to - be either. - So I first start with... We start with - the human being at the middle and the - people we serve, - and we're all subject to the same systems - requirements. - For that reason and the challenges that prior - authorization puts in the middle of care at - times between the patient and the doctor and - the... And and their financing institution, which is - the insurer,

- we did make, as an industry, a major - commitment in 2025 - to not only reduce the amount of prior - authorizations, but to also make the prior authorizations - that remain - easier, simpler, - faster, - more transparent. - I can tell you firsthand sitting on the - front lines of this work that there isn't - a payer that isn't steeply serious about trying - to make this better. - This is more than just about going halfway - across the bridge. I think most payers are - trying to go further than halfway across the

- bridge and working with providers to make this - better. - You cited it. - Last year alone, there were six and a - half million fewer prior authorizations - as a result of the work that we - did as an org... As as payers within - this space. There's there's probably - more to do. - And yet - what we're really focused on now, and you - also touched on it in your question, is - making the prior authorizations that remain - faster and almost invisible, - happening in real time. And, again, back to - data and technology,

- it... The systems that are emerging today allow - us to move more quickly - with clear data exchange between payers and providers, - APIs that that force those connections to happen - more quickly, - digitizing all of the medical policies behind the - scenes to make sure that, - the real time decision engines can happen in - real time. - But it also requires... And this is, I - think, an important point to end with, is - that while we're doing all of the major

- investment work of our workflows and our technology - stacks to make this happen, - we also need providers to do meet us - a little bit across that bridge too. And - what I mean by that is... And I've - seen two numbers on this. - Few years ago, the latest number I saw - was roughly 40% of the submitted prior authorizations - from providers came in by nonelectronic - means, - which is ludicrous. - We've gotta do better. - I've also seen a number more recently that - puts it at closer to 25%.

- Well, if you split the difference and you - just say roughly... And I'll get benefit of - the doubt, 25%, - 30% - of the submitted prior authorizations today from providers - are nonelectronic. - There's... - I can't fix all of the problem, - with the best technology and the best data - and the best commitment if things are still - coming - in, in a nonelectronic - format. So we really need providers to to - earnestly meet us, on that bridge - if we're truly gonna transform the member experience.

- But I know from our industry's perspective, we're - incredibly committed to it. And I think from - most providers I work with and talk to, - almost all of them are equally committed to - trying to do the same thing. It's just - been a it's been a wedge between us - for far too long. - And there are certain groups that would prefer - it remain a wedge because that's how they - raise money and and stir the pot a - little bit. - But I think if we fundamentally fix the - issue, we can move on from this and - and and take take that out, - from the experience of the health care system.

- Yeah. Absolutely. And then Make it easier. - Yeah. No. Certainly. And it is amazing, when - I speak to leaders like yourself within the - industry when they when they mention, - faxes still being used for things like prior - authorization. - It's commonplace. It's not... It's it's it's not - an unheard of thing. - And so I think in that vein, Sean, - I mean, you just talked about that that - the providers you speak to, they wanna improve - on this this issue as well, and insurers - are working to do the same. So when - we when we do see reports of of

- physician surveys, - still reporting care delays from from prior auth... - Or the - the the the resources, - a lot of - practices and providers are still putting into this, - to this process. - Mhmm. Where do you think the... This this - wedge is still the hardest, - to to navigate? And and, - I I mean, what would it take from - your view to to finally get over this - hump? - Well, I think it's... - Look. I think there's a... If you step - back from it and you say, why did

- prior authorization emerge within the industry to begin - with? It emerged because there was... - There is and remains, - a significant amount - of low value, - care that gets delivered. And in some cases, - you know, fraud, waste, and abuse within the - system. - Yeah. And if you take seriously some of - the reports that suggest it could be upwards - of 20% of the total health care spend, - that's roughly a trillion dollars a year that - would fall into that - either low value or fraud, waste, and abuse

- category. And to be clear, there's there's a - whole spectrum of what those words mean. - But let's take it at face value for - a moment. There's a reason prior authorization emerged, - and there's a reason prior authorization needs to - stay in place - in some categories. - But where - we can remove those blockers where care is - getting approved - anyway, let's remove those hurdles from that process - where we can - without completely removing

- the the value proposition - of catching - bad care or fraudulent care or wasted care - before it happens. - And, ironically, it's... It... It's many of our - employer groups, - small and large businesses, - and even some of our government customers - who are working hard to manage their health - care spend - and want us to have, - effective prior authorization in place, particularly for those - self funded accounts, - but not exclusive to those self funded accounts

- because they understand that this this type of - care, this type of money is being spent - if we don't have those safeguards in place. - So the goal isn't to remove the safeguards. - The goal is to make the safeguards - invisible, quick, reliable, easy... Easily navigatable, - and in real time so that care doesn't - get interrupted. - Yeah. There are there are spots where it - is still challenging to your point, - and I I expect that we will continue - to have speed bumps - over the next several years as we work

- together to try to transition. - Or actually say make good on these commitments - as an industry. - But I I wouldn't wanna let perfect be - the enemy of the good. We're gonna have - speed bumps. We need progress over perfection in - this, and we need willing partners who are - who are willing to go along on that - journey and be part of the solution. - And, you know, one group we don't talk - about very often in these conversations, but I - would I would raise is our our EMR - partners or electronic health record partners.

- They sit at the catbird seat between - the payer interaction and the provider delivering care - to the member in the room. And those - EMR vendors have an enormous opportunity to help - and partner and drive a workflow - transformation - that enables real time authorization with the clinical - record on one side - and the decision making rules and the medical - policy on the other in real time. But - some of those environments are closed environments, and - we're gonna need continued collaboration in that space - Mhmm. From those from those types of partners.

- No. Absolutely. - I wonder too, you know, it seems like - the last couple of years, we've seen a - lot of movement - at the state level in the legislatures, - passing laws all over the country on this - topic of of prior auth, but also limiting - how insurers use AI in in coverage decisions - more broadly, - including in in prior auth requests. And I - I know the... These laws typically fall more - on the the fully insured plans versus self - insured. But I wonder, - you know, given given that and then what

- we've been seeing recently coming out of the - the association's - research around, - AI and its, its impact on coding, - in the provider setting, - What are you hearing right now, - from from members, - from employer clients, - about the use of AI in in health - insurance broadly and - and how to communicate - around this issue, which could... Seems to evolve - very quickly, - around coverage decisions and and how the blue's - system is,

- is thinking about that. - Yeah. I mean, look. - There's... It's an easy it's an easy question - to answer because a... AI is not making - clinical review decisions on behalf of of a - blue or a payer, - for a member. - A qualified clinician reviews any clinical denial, period. - Full stop. - And technology shouldn't be the thing that gets, - in the way. It should make the process - faster and easier, - but not interrupt the human element and the

- human in the loop of of the delivery - of care. This is the most intimate relationship, - I think, in society we have, which is - the relationship between a physician and a member. - And, - there needs to be a human in the - loop on that on all sides of that - equation, whether it's the physician side, whether it's - the EMR vendor, whether it's the payer and - that... For its part of it. - You mentioned, - AI and the work we've done to identify - what many, - provider organizations are using AI for, which is

- revenue cycle management or RCM. Right? So not - to get too acronym y here on a - podcast, but, - look, they... There's been a lot of deployment - to - upcode. - You know? The the the the battle signs - on this are... We'll say it's upcoding. They - might say it's right coding. - Let's split the difference. - At the end of the day, look, provider - organizations are under continuous pressure to to hit - revenue and earnings pressure in some cases, or - in some cases, just - just pay the - bills. And so I understand that pressure to

- try to maximize revenue, - generation, and they're using AI to mine the - clinical records to identify all possible - opportunities for claimable events and billing. - In some cases, it's it's appropriate. And in - other cases, it's been used. - It's it's been distorted, and it's been used. - And we've identified that. We've researched that. We - published that research. It's happening in the industry - broadly. It's unacceptable. - It's unacceptable in the same way that AI - would be used on the payer side to - deny coverage somebody without a human interaction and

- a qualified clinical review of that. So Yeah. - Like like any great tool, - technology has the ability to serve good, and - it has the ability to be abused. And, - I I think in the early days of - artificial intelligence, to your point, - we're gonna continue the need to work together - to rein in the inappropriate uses. - And I think by and large, we have - a lot of people in this industry committed - to doing that. Yeah. No. Absolutely. And it - does seem like, at this point, you'd be - hard pressed to find a a leader in

- in the insurance industry that isn't tying a - line between - AI use, - in the provider office to, - increasing care costs. And so really interesting to - see this happen, bringing us back full circle - to what's causing commercial health care costs to - go up. - So in that vein, you know, the people - listening in, Sean, there there are people in, - positions like yourself all over the country, and - I wonder if there's any final bits of - advice or final - thoughts you would wanna share with them.

- I think the final thought I would have - is - is - when we're in our... When we we as - an industry are in these conversations and we're - working on a day to day basis, - I'm often reminded when I go home to - the kitchen table at night and I sit - with my family, they don't understand about 80 - to 90% of what I tell them I - do during the day. And so I think - we have to step back out of the - acronyms and the lingo - and the sort of, - inward facing nature of our space sometimes - and ask ourselves, is the work we're doing

- resonating with the people that we're supposed to - serve? - And if you put the people that we're - supposed to serve at the center of every - conversation we have, - instead of - putting the institutions at the center of every - conversation we have. And even in this, I'm - guilty of it by talking about payers and - providers and EMR vendors and our government partners. - But when you do it the right way - and you put the member at the center - of everything, you reframe why we're doing this. - You reframe - the definition of the problem, the definition of - the possible solution sets.

- And I would just ask us as an - industry to step back more often - in small meetings and big meetings, - in small small interactions or big, - and start with the human at the center, - the member at the center of everything that - we're doing together. That's who we're here for. - That's who we're supposed to be serving - even when we get caught up in our - own industry jargon and vernacular. - Yeah. I think it reorients all the work - we do when we start with them first - and not ourselves. - Awesome. Well, I think it's a good place - to leave things. Cannot thank you enough for

- taking the time to chat with us and - for sharing your insights with our listeners. We - really appreciate you doing so. Yeah. I'm glad - to be here. Thanks for having me. Yeah. - Absolutely. And to our listeners, if you'd like - to listen to more podcasts from Becker's, you - can visit beckershospitalreview.com.

Open the transcript file

Hosts and Guests

Nobody is credited on this episode yet.

Credit the people on this episode

Be the first to rate this episode

More episodes

All episodes
  1. Payment Integrity Can Protect Savings Without Creating More Friction

    Nov 20, 202619 minAudio

    In this episode, Jon Grandstaff, Senior Vice President of Payment Integrity at Zelis, discusses how payers can reduce payment friction, use AI to support more accurate claims reviews and improve payer-provider...

    Credit the people on this episode

  2. From Learning Collaborative to Gap Closure: How Wisconsin Medicaid Is Telethinking Colorectal Cancer Screening

    Nov 19, 202612 minAudio

    In this episode, Amy Conlon, MPH, Population Health Sr. Manager at Exact Sciences, and Jeff Huebner, MD, FAAFP, Executive Medical Officer, Division of Medicaid Services, Wisconsin Department of Health Services, discuss...

    Credit the people on this episode

  3. What Health Plans Miss When They Look at Markets in Isolation

    Nov 18, 202617 minAudio

    In this episode, Denis Mrkva, Senior Vice President of Analytics Solutions at Data Axle, discusses how health plans can combine consumer, employer, geographic and healthcare data to identify growth opportunities, reduce...

    Credit the people on this episode

  4. Strengthening Provider Networks Through AI, Data and Strategic Partnerships

    Nov 17, 20268 minAudio

    In this episode, Bob Tavernier, Solutions Executive at Quest Analytics®, discusses how health plans can leverage AI, provider data and strategic partnerships to improve network accuracy, strengthen regulatory compliance...

    Credit the people on this episode

  5. Martina Lee Strickland, Head of Marketing, PR and Brand at Clever Care Health Plan

    Nov 16, 202617 minAudio

    In this episode, Martina Lee Strickland, Head of Marketing, PR and Brand at Clever Care Health Plan, joins the podcast to discuss the importance of building trust when serving underserved communities. She also shares...

    Credit the people on this episode